Cargando…
Hot topics from the Assemblies
Summary: Cowie et al. present the results of the international, multicentre, randomised, parallel-group SERVE–HF (Treatment of sleep-disordered breathing with predominant central sleep apnea by adaptive servo ventilation in patients with heart failure) trial, which investigated the effects of adding...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297958/ https://www.ncbi.nlm.nih.gov/pubmed/28210325 http://dx.doi.org/10.1183/20734735.124216 |
| _version_ | 1782505811563511808 |
|---|---|
| collection | PubMed |
| description | Summary: Cowie et al. present the results of the international, multicentre, randomised, parallel-group SERVE–HF (Treatment of sleep-disordered breathing with predominant central sleep apnea by adaptive servo ventilation in patients with heart failure) trial, which investigated the effects of adding adaptive servo-ventilation (ASV) to guideline based medical management on survival and cardiovascular outcomes in patients with heart failure defined as reduced ejection fraction (<45%) and predominant central sleep apnoea (CSA). |
| format | Online Article Text |
| id | pubmed-5297958 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52979582017-02-16 Hot topics from the Assemblies Breathe (Sheff) Expert Opinion Summary: Cowie et al. present the results of the international, multicentre, randomised, parallel-group SERVE–HF (Treatment of sleep-disordered breathing with predominant central sleep apnea by adaptive servo ventilation in patients with heart failure) trial, which investigated the effects of adding adaptive servo-ventilation (ASV) to guideline based medical management on survival and cardiovascular outcomes in patients with heart failure defined as reduced ejection fraction (<45%) and predominant central sleep apnoea (CSA). European Respiratory Society 2016-12 /pmc/articles/PMC5297958/ /pubmed/28210325 http://dx.doi.org/10.1183/20734735.124216 Text en ©ERS 2016 http://creativecommons.org/licenses/by-nc/4.0/ Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0 (http://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Expert Opinion Hot topics from the Assemblies |
| title | Hot topics from the Assemblies |
| title_full | Hot topics from the Assemblies |
| title_fullStr | Hot topics from the Assemblies |
| title_full_unstemmed | Hot topics from the Assemblies |
| title_short | Hot topics from the Assemblies |
| title_sort | hot topics from the assemblies |
| topic | Expert Opinion |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297958/ https://www.ncbi.nlm.nih.gov/pubmed/28210325 http://dx.doi.org/10.1183/20734735.124216 |